These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 26895230)

  • 1. Replication of Associations of Genetic Loci Outside the HLA Region With Susceptibility to Anti-Cyclic Citrullinated Peptide-Negative Rheumatoid Arthritis.
    Viatte S; Massey J; Bowes J; Duffus K; ; Eyre S; Barton A; Worthington J
    Arthritis Rheumatol; 2016 Jul; 68(7):1603-13. PubMed ID: 26895230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic markers of rheumatoid arthritis susceptibility in anti-citrullinated peptide antibody negative patients.
    Viatte S; Plant D; Bowes J; Lunt M; Eyre S; Barton A; Worthington J
    Ann Rheum Dis; 2012 Dec; 71(12):1984-90. PubMed ID: 22661644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of HLA-DRB1 alleles with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in northern east part of Turkey.
    Uçar F; Çapkin E; Karkucak M; Yücel B; Sönmez M; Alver A; Kaklikkaya N; Tosun M; Alemdaroğlu E; Solak M
    Int J Rheum Dis; 2012 Dec; 15(6):538-45. PubMed ID: 23253237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic background of anticyclic citrullinated peptide autoantibody production in Hungarian patients with rheumatoid arthritis.
    Poór G; Nagy ZB; Schmidt Z; Brózik M; Merétey K; Gergely P
    Ann N Y Acad Sci; 2007 Sep; 1110():23-32. PubMed ID: 17911417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smoking increases rheumatoid arthritis susceptibility in individuals carrying the HLA-DRB1 shared epitope, regardless of rheumatoid factor or anti-cyclic citrullinated peptide antibody status.
    Bang SY; Lee KH; Cho SK; Lee HS; Lee KW; Bae SC
    Arthritis Rheum; 2010 Feb; 62(2):369-77. PubMed ID: 20112396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of polygenic risk scores on heritability of anti-CCP level in RA.
    Cui J; Taylor KE; Lee YC; Källberg H; Weinblatt ME; Coblyn JS; Klareskog L; Criswell LA; Gregersen PK; Shadick NA; Plenge RM; Karlson EW
    Genes Immun; 2014 Mar; 15(2):107-14. PubMed ID: 24385024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-B*08 Identified as the Most Prominently Associated Major Histocompatibility Complex Locus for Anti-Carbamylated Protein Antibody-Positive/Anti-Cyclic Citrullinated Peptide-Negative Rheumatoid Arthritis.
    Regueiro C; Casares-Marfil D; Lundberg K; Knevel R; Acosta-Herrera M; Rodriguez-Rodriguez L; Lopez-Mejias R; Perez-Pampin E; Triguero-Martinez A; Nuño L; Ferraz-Amaro I; Rodriguez-Carrio J; Lopez-Pedrera R; Robustillo-Villarino M; Castañeda S; Remuzgo-Martinez S; Alperi M; Alegre-Sancho JJ; Balsa A; Gonzalez-Alvaro I; Mera A; Fernandez-Gutierrez B; Gonzalez-Gay MA; Trouw LA; Grönwall C; Padyukov L; Martin J; Gonzalez A
    Arthritis Rheumatol; 2021 Jun; 73(6):963-969. PubMed ID: 33381897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of HLA-DR3 with anti-cyclic citrullinated peptide antibody-negative rheumatoid arthritis.
    Verpoort KN; van Gaalen FA; van der Helm-van Mil AH; Schreuder GM; Breedveld FC; Huizinga TW; de Vries RR; Toes RE
    Arthritis Rheum; 2005 Oct; 52(10):3058-62. PubMed ID: 16200610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis.
    van Gaalen FA; van Aken J; Huizinga TW; Schreuder GM; Breedveld FC; Zanelli E; van Venrooij WJ; Verweij CL; Toes RE; de Vries RR
    Arthritis Rheum; 2004 Jul; 50(7):2113-21. PubMed ID: 15248208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The HLA-DRB1 shared epitope is not associated with antibodies against cyclic citrullinated peptide in Chinese patients with rheumatoid arthritis.
    Xue Y; Zhang J; Chen YM; Guan M; Zheng SG; Zou HJ
    Scand J Rheumatol; 2008; 37(3):183-7. PubMed ID: 18465452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide association study of determinants of anti-cyclic citrullinated peptide antibody titer in adults with rheumatoid arthritis.
    Cui J; Taylor KE; Destefano AL; Criswell LA; Izmailova ES; Parker A; Roubenoff R; Plenge RM; Weinblatt ME; Shadick NA; Karlson EW
    Mol Med; 2009; 15(5-6):136-43. PubMed ID: 19287509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations between six classical HLA loci and rheumatoid arthritis: a comprehensive analysis.
    Mitsunaga S; Suzuki Y; Kuwana M; Sato S; Kaneko Y; Homma Y; Narita A; Kashiwase K; Okudaira Y; Inoue I; Kulski JK; Inoko H
    Tissue Antigens; 2012 Jul; 80(1):16-25. PubMed ID: 22471586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: contrasting effects of HLA-DR3 and the shared epitope alleles.
    Irigoyen P; Lee AT; Wener MH; Li W; Kern M; Batliwalla F; Lum RF; Massarotti E; Weisman M; Bombardier C; Remmers EF; Kastner DL; Seldin MF; Criswell LA; Gregersen PK
    Arthritis Rheum; 2005 Dec; 52(12):3813-8. PubMed ID: 16320316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles.
    Snir O; Widhe M; von Spee C; Lindberg J; Padyukov L; Lundberg K; Engström A; Venables PJ; Lundeberg J; Holmdahl R; Klareskog L; Malmström V
    Ann Rheum Dis; 2009 May; 68(5):736-43. PubMed ID: 18635594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Association between the synovial expression of cyclic citrullinated peptide and susceptibility variants of HLA-DRB1 shared epitope alleles and PADI 4 gene single nucleotide polymorphisms in patients with rheumatoid arthritis].
    Li HB; Tie N; Jia YF; Shi L; Su Y; Zhang GZ; Wang Y; Bai LJ; Zhao J; Wang J; Xiao Z
    Zhonghua Yi Xue Za Zhi; 2012 Jun; 92(23):1607-11. PubMed ID: 22944128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features.
    Reyes-Castillo Z; Palafox-Sánchez CA; Parra-Rojas I; Martínez-Bonilla GE; del Toro-Arreola S; Ramírez-Dueñas MG; Ocampo-Bermudes G; Muñoz-Valle JF
    Clin Exp Immunol; 2015 Nov; 182(2):119-31. PubMed ID: 26149185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins.
    Huizinga TW; Amos CI; van der Helm-van Mil AH; Chen W; van Gaalen FA; Jawaheer D; Schreuder GM; Wener M; Breedveld FC; Ahmad N; Lum RF; de Vries RR; Gregersen PK; Toes RE; Criswell LA
    Arthritis Rheum; 2005 Nov; 52(11):3433-8. PubMed ID: 16255021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-C alleles confer risk for anti-citrullinated peptide antibody-positive rheumatoid arthritis independent of HLA-DRB1 alleles.
    Nordang GB; Flåm ST; Maehlen MT; Kvien TK; Viken MK; Lie BA
    Rheumatology (Oxford); 2013 Nov; 52(11):1973-82. PubMed ID: 23901134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-CarP antibodies in two large cohorts of patients with rheumatoid arthritis and their relationship to genetic risk factors, cigarette smoking and other autoantibodies.
    Jiang X; Trouw LA; van Wesemael TJ; Shi J; Bengtsson C; Källberg H; Malmström V; Israelsson L; Hreggvidsdottir H; Verduijn W; Klareskog L; Alfredsson L; Huizinga TW; Toes RE; Lundberg K; van der Woude D
    Ann Rheum Dis; 2014 Oct; 73(10):1761-8. PubMed ID: 24812286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations between serum anti-CCP antibody, rheumatoid factor levels and HLA-DR4 expression in Hungarian patients with rheumatoid arthritis.
    Kapitány A; Szabó Z; Lakos G; Aleksza M; Végvári A; Soós L; Karányi Z; Sipka S; Szegedi G; Szekanecz Z
    Isr Med Assoc J; 2008 Jan; 10(1):32-6. PubMed ID: 18300568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.